Philip Bejon
Director Modernising Medical Microbiology
I am Director of Modernising Medical Microbiology, co-leading with Sarah Walker. I was previously Director of the KEMRI-Wellcome Trust Research Programme, a collaborative Programme formed by the Kenya Medical Research Institute (KEMRI), Wellcome and University of Oxford. I am a clinician with specialist training in infectious disease. I have an interest in the evaluation of vaccines, including malaria, yellow fever and Ebola vaccines. I have undertaken studies of naturally acquired immunity to malaria and human challenge models, and have an interest in bone infection and osteomyelitis.
Recent publications
-
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)
Journal article
Lucinde R. et al, (2025), Wellcome Open Research, 7, 269 - 269
-
Nanopore adaptive sampling for bacterial identification from periprosthetic joint replacement tissue
Preprint
Street TL. et al, (2025)
-
Low-Dose Yellow Fever Vaccine in Adults in Africa
Journal article
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
-
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Journal article
Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350
-
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.
Journal article
Miotto O. et al, (2024), The Lancet. Microbe